Robbins LLP Announces Class Action Lawsuit Against Zynex, Inc. for Alleged Securities Fraud

Investor Alert: Class Action Lawsuit Against Zynex, Inc.

Robbins LLP, a prominent law firm specializing in shareholder rights litigation, has informed investors of the initiation of a class action lawsuit against Zynex, Inc. (NASDAQ: ZYXI). The action is on behalf of shareholders who acquired Zynex stocks between March 13, 2023, and March 11, 2025.

Zynex, a medical device manufacturer known for its electrotherapy products aimed at pain management and rehabilitation, is facing allegations that could have serious implications for its shareholders. According to the complaint, the company did not disclose critical information regarding its operations during the class period. Specifically, it is alleged that Zynex shipped an excess of products, which led to an artificial inflation of revenue figures. Insurers, including Tricare — the health insurance program for U.S. military members — began scrutinizing the company, drawing attention to their practices which has raised eyebrows among investors.

Furthermore, the complaint indicates that Zynex may face possible penalties, including the removal from several insurer networks, which could significantly affect its revenue streams and operational viability.

On March 11, 2025, Zynex disclosed its fourth-quarter and full-year results for 2024, revealing a revenue downturn characterized by a substantial shortfall due to delays in payments from key payers. The announcement particularly highlighted that Tricare had temporarily suspended payments while reviewing prior claims, which inevitably led to a drop in Zynex's stock price by 51.3%, closing at $3.41 per share on March 12, 2025.

The law firm Robbins LLP encourages all affected shareholders to understand their rights, as they may be eligible to participate in the lawsuit. Investors looking to serve as lead plaintiffs must file their documentation with the courts by May 19, 2025. This role involves representing the interests of the class as the case progresses, although individuals are not required to actively participate to be eligible for recovery.

Robbins LLP represents clients on a contingency fee model, meaning that shareholders will not incur any fees unless they recover losses through the lawsuit. To explore eligibility or gain more information, shareholders can submit an inquiry through Robbins LLP's contact resources.

About Robbins LLP

Founded in 2002, Robbins LLP has built a reputation as a leader in litigating on behalf of shareholders. Committed to recovering losses, enhancing corporate governance, and holding executives accountable, the firm's extensive experience aims to foster fair practices in the corporate world.

To stay updated on any developments related to the class action against Zynex, or to receive alerts regarding corporate misconduct, interested parties are encouraged to sign up for Stock Watch, a service provided by Robbins LLP.

As always, past results in similar litigation do not guarantee future success, but Robbins LLP's commitment to shareholder advocacy remains steadfast.

For inquiries, potential class members can also reach out to Attorney Aaron Dumas, Jr. at Robbins LLP or call at (800) 350-6003 for assistance.